Leukemia and Lymphoma Laboratory

Gerald V. Denis, Ph.D.
Associate Professor

Education:

Ph.D., University of California, Berkeley
Postdoc, University of Massachusetts Medical Center

General field of research:

Cancer

Affiliations other than medicine:

Evans Center for Interdisciplinary Biomedical Research
Department of Pharmacology
Hematology/Oncology Section
Program in Molecular Medicine
Obesity and Diabetes
Boston Obesity Nutrition Research Center
Flow Cytometry Core Facility

Contact information:

Office
Conte Building, K520
Phone: 617-414-1371

Lab
Phone: 617-414-1372
Fax: 617-638-5673

gdenis@bu.edu

Research group information

Fangnian Wang, postdoc

Wanda Blanton, Immunology Training Program fellow

Anna Belkina, graduate student

Hongsheng Liu, research associate

Other research websites:

http://www.bumc.bu.edu/immunology/

http://www.bumc.bu.edu/hematology/hematology-training-grant/

http://www.bumc.bu.edu/gpmm/

Keywords:

Cancer, stem cells, cancer therapeutics, insulin resistance, obesity, chromatin

Summary of research interest:

The overall goal of my lab is to understand the fundamental mechanisms of transcriptional control of growth and development, and particularly, how chromatin-based disruptions of the eukaryotic cell cycle can lead to malignancy. We focus on the functions of the bromodomain protein Brd2. Results to date have broad significance for our understanding of adaptive immunity, B cell proliferation and non-Hodgkin’s lymphoma (NHL). New results with Brd2 knockdown models have important implications for obesity and insulin resistance.

leukemialab_brdu leukemialab_machine
leukemialab_sidepop

Recent publications:

Greenwald et al (2004) E-mu-BRD2 transgenic mice develop B cell lymphoma and leukemia. Blood 103: 1475–1484. PMID: 14563639

Sinha et al (2005) Bromodomain analysis of Brd2-dependent transcriptional activation of cyclin A. Biochem. J. 387: 257–269. PMID: 15548137

Denis et al (2006) Identification of transcription complexes that contain the double bromodomain protein Brd2 and chromatin remodeling machines. J. Proteome Res. 5: 502–511. PMID: 16512664

You et al (2006) The Kaposi’s Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J. Virol. 80: 8909–8919. PMID: 16940503

Lenburg et al (2007) Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis. J. Biol. Chem. 282: 4803–4811. PMID: 17166848

Longe et al (2009) Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: Mechanism and therapeutic potential. Int. J. Cancer. 124:473–482. PMID: 19003960

Romesser et al (2009) Development of a malignancy-associated proteomic signature for diffuse large B cell lymphoma. Am. J. Pathol. in press.

Technologies available for sharing upon request:

Retroviral injections and lentivirus production